Change search
ReferencesLink to record
Permanent link

Direct link
Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of Tc-99m-Labeled Anti-HER2 Affibody Molecules
Show others and affiliations
2008 (English)In: Bioconjugate chemistry, ISSN 1043-1802, E-ISSN 1520-4812, Vol. 19, no 12, 2568-2576 p.Article in journal (Refereed) Published
Abstract [en]

The effects of polar (mercaptoacetyl-triseryl) and negatively charged (mercaptoacetyl-triglumatyl) chelators on the biodistribution of Tc-99m-labeled anti-HER2 Affibody molecules were previously investigated. With glycine, serine, and glutamate, we demonstrated that substitution with a single amino acid in the chelator can significantly influence the biodistribution properties and the excretion pathways. Here, we have taken this investigation further, by analyzing the effects of introduction of a positive amino acid residue on the in vivo properties of the Tc-99m-labeled Affibody molecule. The Affibody molecules with mercaptoacetyl-seryl-lysyl-seryl (maSKS) and mercaptoacetyl-trilysyl (maKKK) extensions were produced by peptide synthesis and labeled with Tc-99m in alkaline conditions. A comparative biodistribution was performed in normal mice to evaluate the excretion pathway. A shift toward renal excretion was obtained when serine was substituted with lysine in the chelatin sequence. The radioactivity in the gastrointestinal tract was reduced 3-fold for the Tc-99m-maSKS-Z(HER2:342) and Tc-99m-maKKK-Z(HER2:342) in comparison with the Tc-99m-maSSS-Z(HER2:342) conjugate 4 h post injection (p.i.). The radioactivity in the liver was elevated when a triple substitution of positively charged lysine was used. The tumor targeting properties of Tc-99m-maSKS-Z(HER2:342) were further investigated in SKOV-3 xenografts. The tumor uptake of Tc-99m-maSKS-Z(HER2:342) was 17 +/- 7% IA/g 4 h p.i. Tumor xenografts were well-visualized by gamma scintigraphy. In conclusion, the substitution with one single lysine in the chelator results in better tumor imaging properties of the Affibody molecule Z(HER2:342) and is favorable for imaging of tumors and metastases in the abdominal area. Multiple lysine residues in the chelator are, however, undesirable due to elevated uptake both in the liver and kidneys.

Place, publisher, year, edition, pages
2008. Vol. 19, no 12, 2568-2576 p.
Keyword [en]
of-clinical-oncology, malignant-tumors, her2 expression, breast-cancer, protein, therapy, recommendations, conjugate, chemistry, tc-99m
URN: urn:nbn:se:kth:diva-18056DOI: 10.1021/bc800244bISI: 000261767800036ScopusID: 2-s2.0-58149083156OAI: diva2:336102
QC 20100525Available from: 2010-08-05 Created: 2010-08-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Eriksson Karlström, Amelie
By organisation
Molecular Biotechnology
In the same journal
Bioconjugate chemistry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 28 hits
ReferencesLink to record
Permanent link

Direct link